Successful strategy for merge and acquisition

Published: 2008-01-03 07:00:00

Updated: 2008-01-03 07:00:00

Consolidation and convergence will likely be accelerating across the domestic pharmaceutical industry within a couple of years in the changing business environment of the 21st century, but Korean firms are still showing a passive attitude towards mergers and acquisitions (M&As) due to the lack of...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK